Keywords
COVID-19; SARS-CoV-2; BA.5; Omicron; Paxlovid; CDC: Centers for Disease Control and Prevention; FDA: U.S. Food and Drug Administration; WHO: World Health Organization
Abstract
NA
Most read articles by the same author(s)
- Sohail Rao, Manish Singh, The Newly Detected B.1.1.529 (Omicron) Variant of SARS-CoV-2 With Multiple Mutations , DHR Proceedings: Vol. 1 No. S5 (2021): Fourth Quarter 2021
- Sohail Rao, MD, FACS, The Should Healthcare Facilities Mandate COVID-19 Vaccination of its Employees? , DHR Proceedings: Vol. 1 No. S4 (2021): Special Publication
- Sohail Rao, Manish Singh, An Evolving Public Health Crisis Caused by the Rapid Spread of the SARS-CoV-2 Delta Variant , DHR Proceedings: Vol. 1 No. S4 (2021): Special Publication
- Sohail Rao, Manish Singh, Will Molnupiravir be the First Oral Treatment for High-Risk Non-Hospitalized Patients with Mild-Moderate COVID-19? , DHR Proceedings: Vol. 1 No. S4 (2021): Special Publication
- Sohail Rao, Manish Singh, Growing Shortage of Healthcare Workers Poses an Existential Threat to the Public Health System , DHR Proceedings: Vol. 1 No. S5 (2021): Fourth Quarter 2021
- Sohail Rao, Manish Singh, The Rising Incidence of SARS-CoV-2 Infection in the Greater Rio Grande Valley: Is the COVID-19 Pandemic Over? , DHR Proceedings: Vol. 2 No. S3 (2022): Second Quarter Editorial
- Sohail Rao, The Use of Transgenic Mosquitoes to Control Vertical Transmission of Arbovirus-related Illnesses , DHR Proceedings: Vol. 1 No. S3 (2021): Editorial: The Use of Transgenic Mosquitoes to Control Vertical Transmission of Arbovirus-related Illnesses
- Sohail Rao, Alec Vasquez-Kanhere, Manish Singh, Insufficient Scientific Evidence Supporting the Use of Ivermectin in the Prevention and Treatment of COVID-19 , DHR Proceedings: Vol. 1 No. S4 (2021): Special Publication
- Sohail Rao, MD, FACS, Natural vs. Vaccine Mediated COVID-19 Immunity , DHR Proceedings: Vol. 1 No. S4 (2021): Special Publication
- Sohail Rao, JIYA DEVANI, DEEPAK SRIVASTAVA, Sociology of Sleep Health in the Rio Grande Valley , DHR Proceedings: Vol. 2 No. S4 (2022): Fourth Quarter